376 related articles for article (PubMed ID: 23732236)
1. Defective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathies.
Kline CF; Mohler PJ
Biochim Biophys Acta; 2014 Feb; 1838(2):723-30. PubMed ID: 23732236
[TBL] [Abstract][Full Text] [Related]
2. The ion channels to cytoskeleton connection as potential mechanism of mechanosensitivity.
Martinac B
Biochim Biophys Acta; 2014 Feb; 1838(2):682-91. PubMed ID: 23886913
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal roles in cardiac ion channel expression.
Steele DF; Fedida D
Biochim Biophys Acta; 2014 Feb; 1838(2):665-73. PubMed ID: 23680626
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
5. Actin directly interacts with different membrane channel proteins and influences channel activities: AQP2 as a model.
Sasaki S; Yui N; Noda Y
Biochim Biophys Acta; 2014 Feb; 1838(2):514-20. PubMed ID: 23770358
[TBL] [Abstract][Full Text] [Related]
6. Membrane channels as integrators of G-protein-mediated signaling.
Inanobe A; Kurachi Y
Biochim Biophys Acta; 2014 Feb; 1838(2):521-31. PubMed ID: 24028827
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic regulation of cardiac ionic channels: role of membrane microdomains in the regulation of kv4 channels.
Gallego M; Alday A; Alonso H; Casis O
Biochim Biophys Acta; 2014 Feb; 1838(2):692-9. PubMed ID: 23811359
[TBL] [Abstract][Full Text] [Related]
8. The anchoring protein SAP97 influences the trafficking and localisation of multiple membrane channels.
Fourie C; Li D; Montgomery JM
Biochim Biophys Acta; 2014 Feb; 1838(2):589-94. PubMed ID: 23535319
[TBL] [Abstract][Full Text] [Related]
9. Ion Transporters, Channelopathies, and Glucose Disorders.
Demirbilek H; Galcheva S; Vuralli D; Al-Khawaga S; Hussain K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137773
[TBL] [Abstract][Full Text] [Related]
10. Alternative paradigms for ion channelopathies: disorders of ion channel membrane trafficking and posttranslational modification.
Curran J; Mohler PJ
Annu Rev Physiol; 2015; 77():505-24. PubMed ID: 25293528
[TBL] [Abstract][Full Text] [Related]
11. Ion channelopathies of the immune system.
Vaeth M; Feske S
Curr Opin Immunol; 2018 Jun; 52():39-50. PubMed ID: 29635109
[TBL] [Abstract][Full Text] [Related]
12. Calcium Channelopathies: Structural Insights into Disorders of the Muscle Excitation-Contraction Complex.
Pancaroglu R; Van Petegem F
Annu Rev Genet; 2018 Nov; 52():373-396. PubMed ID: 30208288
[TBL] [Abstract][Full Text] [Related]
13. Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting.
Mohler PJ; Bennett V
Curr Opin Cardiol; 2005 May; 20(3):189-93. PubMed ID: 15861006
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial channelopathies in aging.
Pi Y; Goldenthal MJ; Marín-García J
J Mol Med (Berl); 2007 Sep; 85(9):937-51. PubMed ID: 17426949
[TBL] [Abstract][Full Text] [Related]
15. Spectrins: a structural platform for stabilization and activation of membrane channels, receptors and transporters.
Machnicka B; Czogalla A; Hryniewicz-Jankowska A; Bogusławska DM; Grochowalska R; Heger E; Sikorski AF
Biochim Biophys Acta; 2014 Feb; 1838(2):620-34. PubMed ID: 23673272
[TBL] [Abstract][Full Text] [Related]
16. Ion Channel Disorders and Sudden Cardiac Death.
Garcia-Elias A; Benito B
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495624
[TBL] [Abstract][Full Text] [Related]
17. Ion channelopathies to bridge molecular lesions, channel function, and clinical therapies.
Carbone E; Mori Y
Pflugers Arch; 2020 Jul; 472(7):733-738. PubMed ID: 32607810
[No Abstract] [Full Text] [Related]
18. Ankyrin-based cellular pathways for cardiac ion channel and transporter targeting and regulation.
Cunha SR; Mohler PJ
Semin Cell Dev Biol; 2011 Apr; 22(2):166-70. PubMed ID: 20934528
[TBL] [Abstract][Full Text] [Related]
19. Relevance of tissue specific subunit expression in channelopathies.
Seitter H; Koschak A
Neuropharmacology; 2018 Apr; 132():58-70. PubMed ID: 28669898
[TBL] [Abstract][Full Text] [Related]
20. Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.
Cunha SR; Mohler PJ
Cardiovasc Res; 2006 Jul; 71(1):22-9. PubMed ID: 16650839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
